SYNERGISTIC APOPTOTIC EFFECTS OF BORTEZOMIB AND METHYLSTAT ON DIFFERENT MULTIPLE MYELOMA CELL LINES

被引：0
|
作者：
Kaci, N. [1 ]
Kiraz, Y. [1 ]
Baran, Y. [1 ]
机构：
[1] Izmir Inst Technol, Mol Biol & Genet, Izmir, Turkey
来源：
HAEMATOLOGICA | 2015年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB1850
引用
收藏
页码：730 / 731
页数：2
相关论文
共 50 条
  • [41] Synergistic DNA-damaging effect in multiple myeloma with the combination of zalypsis, bortezomib and dexamethasone
    Lopez-Iglesias, Ana-Alicia
    Gonzalez-Mendez, Lorena
    San-Segundo, Laura
    Herrero, Ana B.
    Hernandez-Garcia, Susana
    Martin-Sanchez, Montserrat
    Gutierrez, Norma C.
    Paino, Teresa
    Aviles, Pablo
    Mateos, Maria-Victoria
    San-Miguel, Jesus F.
    Garayoa, Mercedes
    Ocio, Enrique M.
    HAEMATOLOGICA, 2017, 102 (01) : 168 - 175
  • [42] The combination of the MTOR inhibitor rapamycin and proteasome inhibitor bortezomib is synergistic in vitro in multiple myeloma
    Leleu, X.
    O'Sullivan, G.
    Jia, X.
    Ngo, H.
    Moreau, A. S.
    Roccaro, A.
    Hatjiharisi, F.
    Hideshima, T.
    Anderson, K.
    Ghobrial, I.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 148 - 149
  • [43] Synergistic apoptotic effects of silibinin in enhancing paclitaxel toxicity in human gastric cancer cell lines
    Zhang, Yuanxin
    Ge, Yakun
    Ping, Xie
    Yu, Ming
    Lou, Dawei
    Shi, Wei
    MOLECULAR MEDICINE REPORTS, 2018, 18 (02) : 1835 - 1841
  • [44] Inhibitory effects of bortezomib on platelet aggregation in patients with multiple myeloma
    Rupa-Matysek, Joanna
    Gil, Lidia
    Wojtasinska, Ewelina
    Nowicki, Adam
    Dytfeld, Dominik
    Kazmierczak, Maciej
    Komarnicki, Mieczyslaw
    THROMBOSIS RESEARCH, 2014, 134 (02) : 404 - 411
  • [45] Outcomes of patients with multiple myeloma refractory to different administration schedules of bortezomib
    Goel, Utkarsh
    Charalampous, Charalampos
    Kapoor, Prashant
    Binder, Moritz
    Buadi, Francis
    Dingli, David
    Dispenzieri, Angela
    Fonder, Amie L.
    Gertz, Morie A.
    Gonsalves, Wilson I.
    Hayman, Suzanne R.
    Hobbs, Miriam A.
    Hwa, Yi Lisa
    Kourelis, Taxiarchis
    Lacy, Martha
    Leung, Nelson
    Lin, Yi
    Warsame, Rahma M.
    Rajkumar, S. Vincent
    Kumar, Shaji
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [46] Tipifarnib and bortezomib are synergistic and overcome cell adhesion-mediated drug resistance in multiple myeloma and acute myeloid leukemia
    Yanamandra, N
    Colaco, NM
    Parquet, NA
    Buzzeo, RW
    Boulware, D
    Wright, G
    Perez, LE
    Dalton, WS
    Beaupre, DM
    CLINICAL CANCER RESEARCH, 2006, 12 (02) : 591 - 599
  • [47] Efficient electroporation of multiple myeloma cell lines
    Steinbrunn, T.
    Chatterjee, M.
    Einsele, H.
    Bargou, R. C.
    Stuehmer, T.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 148 - 148
  • [48] Synergistic cytotoxic effects of zoledronic acid and radiation in human prostate cancer and myeloma cell lines
    Algur, E
    Macklis, RM
    Häfeli, UO
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 61 (02): : 535 - 542
  • [49] Adhesive interactions of human multiple myeloma cell lines with different extracellular matrix molecules
    Kibler, C
    Schermutzki, F
    Waller, HD
    Timpl, R
    Müller, CA
    Klein, G
    CELL ADHESION AND COMMUNICATION, 1998, 5 (04) : 307 - 323
  • [50] AntagomiR-19a Induced Better Responsiveness to Bortezomib in Myeloma Cell Lines
    Kazemi, Azam
    Abroun, Saeid
    Soleimani, Masoud
    CELL JOURNAL, 2021, 23 (05) : 503 - 509
12345